Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Motile sperm domain-containing protein 3 (MOSPD3) is a multi-pass transmembrane protein defined by an N-terminal major sperm protein (MSP) domain and two transmembrane domains. It is highly conserved in mammals and appears to play a role in mitochondrial positioning and the organization of smooth endoplasmic reticulum structures. Studies in mice show that loss of Mospd3 causes lethal defects in right heart ventricle development, suggesting a critical role in embryonic cardiac morphogenesis and possibly in congenital heart disease. There are currently no known direct therapeutic ligands, established disease biomarkers, or notable drug safety considerations associated with this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Motile sperm domain-containing protein 3 (MOSPD3).